Location · San Diego, CA
Clinical trials in San Diego, CA
494 recruiting studies have a site in the San Diego area, and 126 of them accept healthy volunteers. The area includes La Jolla, Chula Vista, Escondido, Oceanside, Carlsbad, Encinitas and nearby cities.
494 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- Recruiting
Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy
Alcyone Therapeutics, Inc
- Location
- Phoenix, AZ + 14 other US sites
- Eligibility basics
- Ages 3+
- RecruitingPhase 3
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Novo Nordisk A/S
- Location
- Alexander City, AL + 129 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study to Evaluate the Efficacy and Safety of Ponesimod (VSP-128) in Patients With Moderately to Severely Active Ulcerative Colitis
Vanda Pharmaceuticals
- Location
- Chula Vista, CA + 1 other US site
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Novo Nordisk A/S
- Location
- Escondido, CA + 17 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Alleviant ALLAY-HF Study
Alleviant Medical, Inc.
- Location
- Tucson, AZ + 42 other US sites
- Eligibility basics
- Ages 40+
- RecruitingPhase 2
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
AbbVie
- Location
- Huntsville, AL + 32 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
Study of DONQ52 in Active Celiac Disease
Chugai Pharmaceutical
- Location
- Anniston, AL + 57 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
C. R. Bard
- Location
- La Jolla, CA + 13 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
X4 Pharmaceuticals
- Location
- Phoenix, AZ + 20 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 2
A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Enveda Therapeutics
- Location
- Encinitas, CA + 8 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant
Renovion, Inc.
- Location
- Los Angeles, CA + 17 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 1/Phase 2
A Study of DB-OTO, an Adeno-Associated Virus (AAV) Based Gene Therapy, in Children/Infants, Adolescents and Adults With Hearing Loss Due to Otoferlin Mutations
Regeneron Pharmaceuticals
- Location
- Los Angeles, CA + 8 other US sites
- Eligibility basics
- Any age listed
- RecruitingPhase 3
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Eidos Therapeutics, a BridgeBio company
- Location
- La Jolla, CA + 39 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
ATLAS (AltaValve) Pivotal Trial
4C Medical Technologies, Inc.
- Location
- Phoenix, AZ + 35 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
FORWARD CAD IDE Study
Shockwave Medical, Inc.
- Location
- La Jolla, CA + 27 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety
Praxis Precision Medicines
- Location
- San Diego, CA + 5 other US sites
- Eligibility basics
- Ages 0 mo–18
- RecruitingPhase 4
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
Aurinia Pharmaceuticals Inc.
- Location
- La Mesa, CA + 26 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Artiva Biotherapeutics, Inc.
- Location
- Tuscaloosa, AL + 29 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
W.L.Gore & Associates
- Location
- La Jolla, CA + 30 other US sites
- Eligibility basics
- Ages 18–70
- Recruiting
GORE® ENFORM Biomaterial Product Study
W.L.Gore & Associates
- Location
- San Diego, CA + 6 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Immunovant Sciences GmbH
- Location
- Huntsville, AL + 47 other US sites
- Eligibility basics
- Ages 18–80
- Recruiting
Paclitaxel-Coated Balloon Treatment of Chronic Rhinosinusitis
Airiver Medical, Inc.
- Location
- Birmingham, AL + 9 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Antibiotic Device for Osteomyelitis of the Extremities Pivotal Trial - Genex With Gentamicin.
Biocomposites Ltd
- Location
- San Diego, CA + 3 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Syndeio Biosciences, Inc
- Location
- Phoenix, AZ + 22 other US sites
- Eligibility basics
- Ages 18–64